CAMBRIDGE, Mass.–(BUSINESS WIRE)–Bicara Therapeutics, a clinical-stage biotechnology company developing dual-action biologics to elicit a potent and durable immune response, today announced that it will present preclinical data supporting the ongoing clinical development of the lead investigational candidate BCA101, a bifunctional antibody designed to sequester the immunosuppressive TGF-β in the tumor microenvironment (TME) of EGFR+ tumors, … [Read more…]

AcuityMD enables Dilon to quickly identify the right doctors and medical facilities in urgent need of its life-saving medical technology BOSTON–(BUSINESS WIRE)–AcuityMD, providers of a novel commercial platform for medical technology (MedTech) companies, has signed a multi-year contract with Dilon Technologies, a global leader in devices for breast cancer treatment and diagnosis. Dilon is using … [Read more…]

Firm to Build Life Science Companies Focused on Groundbreaking Curative Technologies BOSTON–(BUSINESS WIRE)–Cure Ventures (“Cure”), a life sciences venture capital firm focusing on company formation around groundbreaking curative technologies, today announced the closing of its inaugural fund, Cure Ventures Fund I, L.P., at its targeted hard-cap of $350 million in capital commitments. The fund is … [Read more…]

NEW YORK–(BUSINESS WIRE)–#Acquisition–H.I.G. Capital (“H.I.G.”), a leading global alternative investment firm with $55 billion of equity capital under management, is pleased to announce that its portfolio company, Formerra, LLC (“Formerra” or the “Company”), the leading distributor of highly engineered thermoplastic resins, additives, and other specialty polymers in North America, has acquired Total Polymer Solutions (“TPS”). … [Read more…]

DAYTON, Ohio–(BUSINESS WIRE)–Dr. Michael Verdon, DO, FACOS, a board-certified Neurosurgeon at Dayton Neurological Associates, has partnered with Marvel Group, a value-added medical device company, to offer the first-ever spine surgery warranty in Dayton, Ohio. “We offer people confidence in the results of spinal fusion surgery when they need it the most,” said Michael Verdon, DO, … [Read more…]

EMERYVILLE, Calif.–(BUSINESS WIRE)–Vivani Medical, Inc. (NASDAQ: VANI) (the “Company” or “Vivani”), an emerging biopharmaceutical company which develops miniaturized, subdermal implants today announced that the Company received notice from the National Institutes of Health (“NIH”) of approval of the year 5 funding for the Early Feasibility Clinical Study of the Orion Visual Cortical Prosthesis being conducted … [Read more…]

GAINESVILLE, Fla.–(BUSINESS WIRE)–The U.S. Army Medical Research and Development Command (USAMRDC) recently awarded MLM Biologics, Inc. almost $1.5 million to develop a device to prevent infection in battlefield wounds. The device will incorporate MLM Biologic’s proprietary collagen processing and stabilization technologies. MLM Biologics competed for the award in the battlefield treatment area, focused on preventing … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Immunoglobulins: Global Market Outlook” report has been added to ResearchAndMarkets.com’s offering. The global immunoglobulins (IG) market was estimated to be $18.5 billion in 2021. The immunoglobulins market is projected to grow at a compound annual growth rate (CAGR) of 6.2% and is expected to reach $26.3 billion by the end of 2027. Increasing … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Clinical Trial Supply & Logistics Market Size, Share & Trends Analysis Report By Service (Logistics & Distribution, Storage & Retention), By Phase, By Region, And Segment Forecasts, 2023 – 2030” report has been added to ResearchAndMarkets.com’s offering. The global clinical trials supply & logistics market is expected to reach USD 6.3 billion by … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Active Pharmaceutical Ingredients (API) Global Market – Forecast To 2029” & “Pharmaceutical Excipients Global Market – Forecast To 2029” report has been added to ResearchAndMarkets.com’s offering. The API global market is expected to grow at a high single digit CAGR from 2022 to 2029 to reach $388,002.4 million by 2029 The major factors … [Read more…]